Good Bad Billionaire cover image

Kiran Mazumdar-Shaw: Beer, brewing and biotech

Good Bad Billionaire

00:00

Biocon's Bold Shift: From Brewing to Biotech

This chapter explores Biocon's strategic pivot to the pharmaceutical sector, emphasizing its success in manufacturing generic medicines and producing insulin. It highlights the company's IPO triumph, the rise of its self-made billionaire leader, and the controversies faced during its ambitious journey in the global market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app